HBM BioVentures

de

Net Asset Value (NAV)

Financial Reports

Share Buyback Programme

Management Transactions

Disclosure of Shareholdings

Company Presentation

News Registration

Credits

Editorial		HBM Bio Ventures Ltd
Concept		www.weber-thedy.com
Realisation		www.ncc.ch / www.mesch.ch
Design		www.kimkueng.ch

© 2007 HBM BioVentures Ltd. All rights reserved.

News

Press Releases
»	HBM BioVentures Quarterly Report as at 30 June 2010
»	HBM BioVentures’ largest public investment – Micrus – acquired by Johnson & Johnson
»	HBM BioVentures sells USD hedging position at a profit
»	Shareholders’ meeting approves all proposals by Board of Directors by large majority; Hans Peter Hasler appointed as new Chairman of the Board of Directors; Astellas, which recently acquired OSI Pharmaceuticals, will retain HBM BioVentures shares and intensify cooperation
»	Archive

Financial Reports

»	Quarterly Report June 2010
»	Annual Report 2009/2010
»	Archive

Share Price

SIX Swiss Exchange Ticker
HBMN

Key Figures

as at 31.8.2010	CHF

NAV per share	62.58
Net assets	616 Mio.

Search

News Registration